BioUtah, the trade association representing Utah's life sciences community, has announced that early bird registration is now open for the 2026 Utah Life Sciences Summit (ULSS). The summit, presented by Mayer Brown, will take place on November 11 at the Hilton Salt Lake City Center. Early bird pricing will be available until October 11, offering attendees a reduced rate to participate in one of the region's premier life sciences events. For full details and to register, click here.
The announcement carries significant implications for Utah's life sciences industry, which has become a key driver of the state's economy and a major contributor to healthcare innovation. By bringing together industry leaders, researchers, and policymakers, the summit aims to foster collaboration and address critical issues facing the sector. The early bird discount is designed to encourage broad participation, ensuring that a diverse range of stakeholders can attend and contribute to the conversation.
A highlight of this year's summit is the keynote speaker, Dr. Michelle Tarver, Director of the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration. Dr. Tarver will host an in-person Town Hall discussion, providing attendees with a rare opportunity to engage directly with a top FDA official. This interaction is particularly important for medical device and diagnostic companies in Utah, as CDRH oversees the regulation of these products. The Town Hall format allows for a two-way dialogue, enabling industry professionals to ask questions and gain insights into regulatory priorities and processes.
The summit will also feature topic-specific tracks, including workforce development, regulatory affairs, legal considerations, and artificial intelligence. These tracks reflect the evolving landscape of the life sciences industry, where advances in AI are transforming research and development, and where workforce challenges and regulatory complexities remain top concerns. By offering specialized sessions, the summit provides targeted value to attendees from various segments of the industry, from startups to established companies.
Utah's life sciences sector encompasses a broad spectrum of activities, including medical device manufacturing, biotechnology, biopharmaceuticals, diagnostics, and research and testing. The state has cultivated a robust ecosystem that supports innovation and commercialization, attracting investment and talent. BioUtah, as an independent 501(c)(6) trade association, plays a pivotal role in advocating for this ecosystem and facilitating connections among its members. The annual summit is a cornerstone of these efforts, serving as a platform for networking, knowledge sharing, and strategic discussions.
The decision to hold the summit at the Hilton Salt Lake City Center underscores the event's accessibility and its importance as a central gathering point for the regional life sciences community. With early bird registration now open, organizers anticipate strong interest, given the high-profile keynote and the timely topics on the agenda. Stakeholders are encouraged to take advantage of the discounted rate before the October 11 deadline. For more information about BioUtah and its initiatives, visit the association's website.
As the life sciences industry continues to navigate a rapidly changing environment, events like the Utah Life Sciences Summit provide essential opportunities for professionals to stay informed, build partnerships, and drive innovation. The 2026 summit promises to be a vital forum for shaping the future of healthcare in Utah and beyond.
